Delcath Systems, Inc.

DCTH ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-45.1M $-18.0M $-14.7M $-17.4M $-30.3M $-51.9M $-30.9M $-46.7M
Depreciation & Amortization — — — — — — — —
Depreciation $310.0K $305.0K $617.0K $958.0K $1.1M $1.3M $1.0M $472.0K
Amortization — — — — — — — —
Stock-Based Compensation — — — — — — — —
Net Cash from Operating Activities $-15.4M $-14.2M $-16.4M $-15.6M $-34.1M $-50.0M $-37.4M $-24.1M
Investing Activities
Capital Expenditures $524.0K $258.0K $170.0K $44.0K $142.0K $2.1M $2.6M $1.6M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-524.0K — — — $-142.0K $2.9M $-6.1M $-3.1M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — $0 $0
Net Cash from Financing Activities $-10.5M — — — $41.7M $45.1M $23.6M $37.3M
Net Change in Cash $-410.0K $-8.2M $-7.9M $-10.8M $7.5M $-2.1M $-19.8M $10.1M
Free Cash Flow $-15.9M $-14.5M $-16.6M $-15.6M $-34.2M $-52.1M $-40.0M $-25.7M
← Newer Page 2 of 3 Older →